Mylan’s Meda unit amends loan to omit financial reporting covenant

By Marisa Wong

Morgantown, W.Va., Nov. 14 – Mylan NV subsidiary Meda AB amended its facilities agreement dated Dec. 17, 2014 with Danske Bank A/S as agent to remove a covenant, according to an 8-K filing with the Securities and Exchange Commission.

The amendment eliminates the covenant requiring Meda to deliver its consolidated quarterly and annual financial statements to Danske.

Mylan is a global pharmaceutical company based in Hatfield, England.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.